Trump 2019: Three Things To Expect in Health Care
Client Alert | less than 1 min read | 12.12.18
As part of our Trump 2019: What To Expect series, Traci Vitek, senior policy director with the firm, and Jerrica Mathis, director in Crowell & Moring’s Government Affairs Group, sit down to discuss what we can expect Congress and the White House to focus on in 2019 regarding health care.
Discussed in this 24-minute podcast:
- Health care plans and how they are marketed.
- Drug pricing proposals.
- Congressional oversight.
Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
